Form 4 for AXGN Axogen, Inc.
Accepted 2025-05-23 00:00:00 ET · period of report 2025-05-22 · accession 0000805928-25-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-23 | 2025-05-22 | AXGN | TYNDALL JOSEPH A. | Dir | S - Sale+OE | $11.20 | -20.1K | 15.3K | -57% | -$224.7K |
| D | 2025-05-23 | 2025-05-22 | AXGN | TYNDALL JOSEPH A. | Dir | M - OptEx | $6.30 | +12.8K | 35.4K | +57% | +$81.0K |
| D | 2025-05-23 | 2025-05-22 | AXGN | TYNDALL JOSEPH A. | Dir | M - OptEx | $6.30 | -12.8K | 7,586 | -63% | -$81.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-22 | S | D | 12,850 | $11.20 | 22,557 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $11.15 to $11.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-05-22 | M | A | 12,850 | $6.30 | 35,407 | D | — | — | |
| 3 | Common | Common Stock | 2025-05-22 | S | D | 7,212 | $11.20 | 15,345 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares of common stock were sold in multiple transactions at prices ranging from $11.15 to $11.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (right to purchase) | 2025-05-22 | M | D | 12,850 | $6.30 | 7,586 | D | $6.30 · — to 2033-09-01 | 12,850 Common Stock | (F3) Options vested on the first anniversary of the grant date, which was September 1, 2023. |